Papulopustular Rosacea

Inclusion Criteria

- male and female patient at least 18 years of age
 - signed informed consent
 - Papulopustular rosacea with a minimum of 10 and a maximum of 50 papules and/or pustules, persistent erythema, and telangiectasia 
 - Ability and willingness to accept and comply with treatment and required medical examinations

Exclusion Criteria

- Known non-responders to azelaic acid 
 - Erythematotelangiectatic, rhinophymatous, ocular, or steroid rosacea 
 - Presence of dermatoses that could interfere with the rosacea diagnosis 
 - Treatment with isotretinoin in the six months prior to randomization 
 - Treatment of the face with topical retinoids during the two weeks prior to randomization 
 - Treatment with oral antibiotics during the four weeks prior to randomization
 - Treatment with topical antibiotics
 - Treatment with systemic corticosteroids during 4 weeks prior to randomization
 - Treatment of the face with topical corticosteroids during 2 weeks prior to randomization
 - Treatment of the face with topical imidazole antimycotics during 2 weeks prior to randomization
 - Treatment of the face with topical azelaic acid formulations during 2 weeks prior to randomization
 - Use of a sauna during 2 weeks prior to randomization and during the study
 - Facial laser surgery for telangiectasia during 6 weeks prior to randomization
 - Planned concurrent use of any treatment other than study medication that affects rosacea
 - History of hypersensitivity to propylene glycol or any other ingredient of the study drugs
 - Participation in another clinical trial during the last 4 weeks